About admin

This author has not yet filled in any details.
So far admin has created 6904 blog entries.

Q&A: Does handwashing stem the transmission of Covid-19?

By |2021-02-19T07:09:46+00:00February 19th, 2021|

Is handwashing still an important way to reduce the spread of Covid-19?In the early days of the pandemic, public health experts emphasised handwashing as a way to prevent infection and the government launched a “Hands, Face, Space” campaign to encourage people to wash their hands, wear masks and keep 2 metres apart. Subsequent research has [...]

Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021

By |2021-02-19T07:09:45+00:00February 19th, 2021|

Summary What is already known about this topic? Universal masking is recommended to slow the spread of COVID-19. Cloth masks and medical procedure masks substantially reduce exposure from infected wearers (source control) and reduce exposure of uninfected wearers (wearer exposure). What is added by this report?CDC conducted experiments to assess two ways of improving the fit [...]

Australian breakthrough is the new alternative to milk pasteurization

By |2021-02-19T07:09:43+00:00February 19th, 2021|

From “down under” comes news that is said to be the biggest breakthrough in dairy safety since pasteurization. It has been accepted as “an alternative treatment to pasteurization of raw milk” by Dairy Food Safety Victoria (DFSV) with financial support from both the Queensland state government putting in $190,000 and the Australian Federal Government $761,700. Australia-based [...]

WHO green-lights AstraZeneca COVID vaccine for urgent use

By |2021-02-18T06:50:45+00:00February 18th, 2021|

The World Health Organization (WHO) today announced that the AstraZeneca-Oxford COVID-19 vaccine made in two different countries is listed for emergency use, clearing the final hurdle for doses to be distributed by the COVAX program. In other developments, WHO officials said multiple factors are probably responsible for a drop in global cases, and the European Centre [...]

COVID-19 vaccine in high demand across US, but supply limited

By |2021-02-18T06:50:43+00:00February 18th, 2021|

Across the country, states are expanding vaccination criteria and opening mass COVID-19 vaccination sites to an eager population. But, as the New York Times reports, few states claim they have enough vaccine supply to meet demand. The Centers for Disease Control and Prevention (CDC) COVID Data Tracker shows that 70,057,800 COVID-19 vaccine doses have been delivered in the United States, and 52,884,356 [...]

Non-COVID kids’ hospital cases nearly halved early in pandemic

By |2021-02-18T06:50:42+00:00February 18th, 2021|

US pediatric non–COVID-19 hospitalizations fell up to 45.4% amid the pandemic and related lockdowns compared with previous years, a study published late last week in JAMA Network Open finds. Children’s Hospital of Philadelphia researchers conducted a retrospective analysis of the Pediatric Health Information Systems database of 5,424,688 admissions of 3,372,839 children to 49 hospitals from Jan 1, 2010, to [...]

Guinea reports deadly Ebola outbreak as vaccination begins in DRC

By |2021-02-18T06:50:40+00:00February 18th, 2021|

Health officials in Guinea yesterday reported an Ebola outbreak in the southeast, marking the first reappearance of the virus in the country since West Africa’s massive outbreak that spanned 2014 to 2016. Also, another illness was confirmed in the Democratic Republic of the Congo (DRC), which is battling a flare-up in North Kivu province, the epicenter [...]

CDC issues health advisory on extensively drug-resistant typhoid

By |2021-02-18T06:50:39+00:00February 18th, 2021|

The Centers for Disease Control and Prevention (CDC) says that it has identified nine US cases of extensively drug-resistant (XDR) typhoid fever that aren’t linked to travel. The news came in a Health Advisory issued late last week by the CDC, which said that, as of Jan 14, it has received 71 reports of XDR typhoid infections [...]

QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial

By |2021-02-18T06:50:38+00:00February 18th, 2021|

Background Bedaquiline and delamanid are the first drugs of new classes registered for tuberculosis treatment in 40 years. Each can prolong the QTc interval, with maximum effects occurring weeks after drug initiation. The cardiac safety and microbiological activity of these drugs when co-administered are not well-established. Our aim was to characterise the effects of bedaquiline, delamanid, [...]

Severe Acute Neurologic Involvement in Children With Hemolytic-Uremic Syndrome

By |2021-02-18T06:50:37+00:00February 18th, 2021|

BACKGROUND AND OBJECTIVES: Acute severe neurologic involvement is the most threatening complication in children with hemolytic-uremic syndrome (HUS). Our primary study objectives were to describe the association between acute neurologic manifestations (ANMs) and in-hospital mortality among children with HUS. METHODS: Using the Pediatric Health Information System database, in this retrospective multicenter cohort study, we identified the [...]